Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study-Reference-Cited by-同舟云学术

Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study

Published:2019-11 Issue:11 Volume:20 Page:1518-1530
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Agarwal Neeraj,McQuarrie Kelly,Bjartell Anders,Chowdhury Simon,Pereira de Santana Gomes Andrea J,Chung Byung Ha,Özgüroğlu Mustafa,Juárez Soto Álvaro,Merseburger Axel S,Uemura Hirotsugu,Ye Dingwei,Given Robert,Cella David,Basch Ethan,Miladinovic Branko,Dearden Lindsay,Deprince Kris,Naini Vahid,Lopez-Gitlitz Angela,Chi Kim N

Publisher

Elsevier BV

Subject

Oncology

Reference21 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Prostate cancer in Asia: a collaborative report;Chen;Asian J Urol,2014

3. Targeting metastatic hormone sensitive prostate cancer: chemohormonal therapy and new combinatorial approaches;Damodaran;J Urol,2019

4. Androgen deprivation of prostate cancer: leading to a therapeutic dead end;Katzenwadel;Cancer Lett,2015

5. Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019);James;Eur Urol,2015

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale;Clinical Genitourinary Cancer;2024-12

2. Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations;Acta Dermato-Venereologica;2024-09-04

3. Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting;Journal of Health Economics and Outcomes Research;2024-08-19

4. Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting;Journal of Health Economics and Outcomes Research;2024-08-19

5. Multidisciplinary real-world management of metastatic castration-sensitive prostate cancer: A French national study (PROFILE study);The French Journal of Urology;2024-07